Research conducted by Biogen and the website PatientsLikeMe indicates that wearable activity tracking devices could be useful to patients with multiple sclerosis (MS) in managing their disease. A total of 248 PatientsLikeMe members were recruited for this study to assess the feasibility of using a consumer wearable device to monitor activity in patients with MS in a real-world setting. Participants were mailed a Fitbit One activity tracker with instructions for use and authorization of data sharing between the device manufacturer and PatientsLikeMe. Over the course of the study, the MS patients took 15 million steps and walked 6,820 miles. Of the 191 participants who completed the post-study survey, 88% stated that the device was easy to use and incorporate into their daily routines. In addition, 83% planned to continue using the device after the conclusion of the study and 68% believed that the device would be helpful to them in managing their MS.4

Fitbit One. Activity statistics upload wirelessly to mobile devices. $94.95.